Carberry Christine A. 4
4 · KERYX BIOPHARMACEUTICALS INC · Filed Jan 22, 2018
Insider Transaction Report
Form 4
Carberry Christine A.
Chief Operating Officer
Transactions
- Sale
Common Stock
2018-01-18$4.87/sh−9,048$44,064→ 75,952 total
Footnotes (2)
- [F1]Sale of a total of 9,048 shares of common stock was made in order to satisfy Ms. Carberry's income tax withholding obligation upon the vesting of 28,334 shares of restricted stock on January 17, 2018. Ms. Carberry had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock.
- [F2]Includes 56,666 shares of restricted stock.